Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors

Journal of Internal Medicine

Volumn 248, Issue 1, 2000, Pages 67-76

  Lechleitner, M ^a   Koch, T ^a   Herold, M ^a   Dzien, A ^b   Hoppichler, F ^c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Medical Center Hentschelhof   (Austria)

^c KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Cardiovascular risk factors; Diabetes mellitus type 1; TNF

Indexed keywords

APOLIPOPROTEIN A1; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; LIPID PEROXIDATION; MALE; METABOLIC REGULATION; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033941219     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00705.x     Document Type: Article

References (59)

1. 1 Kannel WB, McGee DL. Diabetes and cardiovasular risk factors: the Framingham study. Circulation 1979; 59: 8-13.
2. 2 Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
3. 3 Lawson ML, Gerstein HC, Tsui E, Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care 1999; 22: S35-9.
4. 4 Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
5. 5 Wang JM, Walter S, Mantovani A. Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. Immunol 1990; 71: 364-7.
6. 6 Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990; 144: 3034-8.
7. 7 Weber C, Draude G, Weber KS, Wubert J, Lorenz RL, Weber PC. Down-regulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions. Atherosclerosis 1999; 145: 115-23.
8. 8 Libby P, Aikawa M. New insights into plaque stabilisation by lipid lowering. Drugs 1998; 56: S9-13.
9. 9 Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocrin Rev 1988; 9: 57-66.
10. 10 Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-5.
11. 11 Spiegelman BM, Hotamisligil GS. Through thick and thin: wasting, obesity, and TNFalpha. Cell 1993; 73: 625-7.
12. 12 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Sci 1993; 259: 87-91.
13. 13 Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrate. J Biol Chem 1993; 268: 26 055-8.
14. 14 Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor alpha acutely inhibits insulin signaling in human adipocytes. Diabetologia 1998; 47: 515-22.
15. 15 Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signalling from the insulin receptor. PNAS 1994; 91: 4854-8.
16. 16 Hotamisligil GS. The role of TNFalpha and TNF-receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-5.
17. 17 Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C. Gene encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990; 87: 2239-43.
18. 18 Mueller C, Held W, Imobden MA, Carnaud C. Accelerated beta-cell destruction in adoptively transferred autoimmune diabetes correlates with an increased expression of the genes coding for TNF-α and granzyme A in the intra-islet infiltrates. Diabetes 1995; 44: 112-7.
19. low T-cell imbalance, and suppression of type diabetes mellitus result from TNF blocked in NOD-NOD-SCID adoptive T-cell transfer. Diabetologia 1998; 41: 1502-10.
20. 20 Yki-Järvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415-31.
21. 21 Jensen MD, Caruso M, Meiling V, Miles JM. Insulin regulation of lipolysis in non-diabetic and IDDM subjects. Diabetes 1989; 38: 1595-601.
22. 22 Meek SE, Nair S, Jensen MD. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999; 48: 10-14.
23. 23 Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A et al. Tumor necrosis factor-alpha and hyperglycaemia induced insulin resistance. J Clin Invest 1996; 97: 1411-75.
24. 24 Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998; 18: 1199-202.
25. 25 Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications. Diabetes 1999; 48: 1-9.
26. 26 Mattila P, Majuri ML, Mattila PS, Renkonen R. TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand J Immunol 1992; 36: 150-65.
27. 27 Ikuta SK, Irby JA, Shenton BK, Givan AL, Lennard TW. Human endothelial cells: effect of TNF-α on peripheral blood mononuclear cell adhesion. Immunol 1991; 73: 71-6.
28. 3 in human plasma. Clin Chem 1989; 35: 265-70.
29. 29 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
30. 30 Ohkawa H, Ohishi N, Yagi M. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
31. 31 Kauma H, Savolainen MJ, Heikkila R, Rantala RO, Lilja M, Reunanen A, Kensaniemi YA. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Human Genet 1996; 97: 156-62.
32. 32 Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White HF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity induced insulin resistance. Sci 1996; 271: 665-8.
33. 33 Begum N, Ragolia L. Effect of tumor-necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells. Endocrinol 1996; 137: 2441-6.
34. 34 Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-alpha induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and Glut 4 expression without a loss of insulin receptor-induced signal transduction. J Biol Chem 1997; 272: 971-2.
35. 35 Mooradian AD, Reed RL, Meredith KE, Scuderi P. Serum levels of tumor necrosis factor and IL1 alpha and IL1 beta in diabetic patients. Diabetes Care 1991; 14: 63-5.
36. 36 Mysliwska J, Zorena K, Bakowska A, Skuratowicz-Kubica A, Mysliwski A. Significance of tumor necrosis factor alpha in patients with long-standing type-1 diabetes mellitus. Horm Metabol Res 1998; 30: 158-61.
37. 37 Jovinge S, Hamsten A, Tornvall P, Proudler A, Bavenholm P, Ericsson CG et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 1998; 47: 114-8.
38. 2: relationship of the plasma levels of this lipoprotein subspecies to its composition, to the magnitude of postprandial lipaemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-7.
39. 39 Ebeling P, Essen-Gustavsson B, Tuominen JA, Koivisto VA. Intramuscular triglyceride content is increased in IDDM. Diabetologia 1998; 41: 111-5.
40. 40 Seidell JC, Cigolini M, Charzewska J, Ellsinger BM, Björntop P, Hautvast JG, Szostak W. Fat distribution and gender differences in serum lipids in men and women from four European communities. Atherosclerosis 1997; 87: 203-210.
41. 41 Kennedy AL, Lyons TJ. Glycation, oxidation, and lipoxidation in the development of diabetic complications. Diabetes 1997; 46: S14-21.
42. 42 Carantoni H, Abbasi F, Warmerdam F, Klebanow M, Wang PW, Chen YDI et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 1998; 18: 762-7.
43. 43 Van Gaal L, Zhang A, De Steijaert MM, Leeuw IH. Human obesity: from lipid abnormalities to lipid oxidation. Int J Obesity 1995; 19: S21-6.
44. 44 Sakuma N, Hibino T, Sato T, Ohte N, Akita S, Tamai N et al. Levels of thiobarbituric acid-reactive substance in plasma from coronary artery disease patients. Clin Biochem 1997; 30: 505-7.
45. 45 Maziere C, Auclair M, Ronveaux MF, Salmon S, Santu R, Maziere JC. Estrogens inhibit copper and cell-mediated modifications of low density lipoproteins. Atherosclerosis 1991; 89: 179-82.
46. 46 Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995; 73: 374-9.
47. 47 Neish AS, Read HA, Thanos D, Pine R, Maniatis T, Collins T. Endothelial interferon regulatory factor-1 cooperates with NF-kappaΒ as a transcriptional activation of vascular cell adhesion molecule-1. Mol Cell Biol 1995; 15: 2558-69.
48. 48 DeMattia G, Bravi MC, Constanzo A, Laurenti O, Faldetta C, Armiento A et al. Effects of insulin on in vitro and in vivo soluble VCAM-1 release. Diabetologia 1999; 42: 1235-9.
49. 49 Deisher TA, Haddix TL, Montgomery KF, Pohlman TH, Kaushansky K, Harlan JM. The role of protein kinase C in the induction of VCAM-1 expression on human umbilical vein endothelial cells. FEBS Lett 1993; 331: 285-90.
50. 50 Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest 1995; 95: 264-71.
51. 51 Couffinthal T, Duplaa C, Labat L, Lamaziere JM, Moreau C, Printseva O, Bonnet J. Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb 1993; 13: 407-14.
52. 52 O'brien KD, Allen MD, McDonald TO. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implication for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945-51.
53. 53 Camussi G, Turello E, Bussolini FB, Aglioni C. Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Internat Arch Allergy Appl Immunol 1990; 71: 364-7.
54. 54 Zoppini G, Targher G, Cacciatori V, Guerriero A, Muggeo M. Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. Diabetes Care 1999; 22: 1871-4.
55. 55 Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM. relation to metabolic control. Diabetologia 1995; 38: 1122-4.
56. 56 Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y. High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 1998; 138: 35-41.
57. 57 Fasching P, Veitl H, Rohac M, Streli C, Schneider B, Waldhäusl OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrin Metabol 1996; 81: 4313-8.
58. 58 Ceriello A, Falleti E, Motz E, Taboga C, Tonutti L, Ezsol Z et al. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metabol Res 1998; 30: 146-9.
59. 59 Comancini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Rigoni A et al. The expression of adhesion molecules on endothelial cells is inhibited by troglitazone through its antioxidant activity. Cell Adhes Commun 1999; 7: 223-31.